Method Development

Method Development

Tandem Labs offers rapid method development of LC/MS/MS and GC/MS/MS assays to support clinical, pre-clinical and discovery studies.

For each project, Tandem establishes a team based on the complexity of the assay and the experience of individual scientists with similar compounds or chemistries.

Each development team's goal is to establish a method suitable for a given study, whether it is to be conducted under strict GLP requirements or is designed for pre-development discovery.

Tandem Labs conducts method validations in accordance with

  • United States Food & Drug Administration (FDA)
  • Organization for Economic Cooperation and Development (OECD)
  • Japanese Ministry of Health, Labor, and Welfare (MHLW)

as they apply to bioanalytical methods and in accordance with procedures described in Tandem Labs' standard operating procedures (SOPs).

In the past year, Tandem Labs validated well over 100 methods that included assays of up to 12 analytes and those with concentration requirements in the low pg/mL range.